SAMANTHA TRAN

Allopathic & Osteopathic Physicians|Dermatology IRVINE, CA NPI 1306469838

General Payments — all program years on this page

$688.87

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 22
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $588.88 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $587.3420
Travel and Lodging $1.541

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $164.985
PFIZER INC. $126.206
UCB, Inc. $80.792
GENZYME CORPORATION $62.262
Regeneron Healthcare Solutions, Inc. $55.082
Galderma Laboratories, L.P. $28.741
Almirall LLC $24.891
ORGANOGENESIS INC. $23.331
Incyte Corporation $22.611

By program year

Program yearAmountRecords
2023 $99.991
2024 $588.8821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1114223192 Regeneron Healthcare Solutions, Inc. $27.22 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114223198 Regeneron Healthcare Solutions, Inc. $27.86 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120646133 Almirall LLC $24.89 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131524614 PFIZER INC. $20.80 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131533335 PFIZER INC. $13.23 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131534138 PFIZER INC. $21.05 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131548348 PFIZER INC. $21.37 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131576380 PFIZER INC. $26.52 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131582346 PFIZER INC. $23.23 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135341841 Lilly USA, LLC $116.75 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135371482 Lilly USA, LLC $16.13 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135384429 Lilly USA, LLC $19.74 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135401249 Lilly USA, LLC $1.54 10/29/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1135412055 Lilly USA, LLC $10.82 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139815025 GENZYME CORPORATION $29.79 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139815041 GENZYME CORPORATION $32.47 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141281168 Incyte Corporation $22.61 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143301763 UCB, Inc. $38.79 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143301767 UCB, Inc. $42.00 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145332649 Galderma Laboratories, L.P. $28.74 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145450035 Organogenesis Inc. $23.33 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.